Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simak Ali

Showing results (21-30 of 111) with videos related to

Pageof 12
Sort By:
The Journal of Steroid Biochemistry and Molecular Biology|October 4, 2002
Molecular changes associated with the acquisition of oestrogen hypersensitivity in MCF-7 breast cancer cells on long-term oestrogen deprivationChristina M W Chan, Lesley-Ann Martin, Stephen R D Johnston, et al.
Endocrinology|May 8, 2024
Interrogating Estrogen Signaling Pathways in Human ER-Positive Breast Cancer Cells Forming Bone Metastases in MiceJulia N Cheng, Jennifer B Frye, Susan A Whitman, et al.
Bioorganic & Medicinal Chemistry Letters|August 3, 2020
The transcriptional repressor REV-ERB as a novel target for diseaseAmaia Uriz-Huarte, Amrita Date, Heather Ang, et al.
The Journal of Organic Chemistry|June 8, 2011
Conversion of α-amino acids into bioactive o-aminoalkyl resorcylates and related dihydroxyisoindolinonesBhavesh H Patel, Andrew M Mason, Hetal Patel, et al.
Nature Communications|March 17, 2018
Light-triggered enzymatic reactions in nested vesicle reactorsJames W Hindley, Yuval Elani, Catriona M McGilvery, et al.
Oncotarget|March 25, 2014
Engineered repressors are potent inhibitors of androgen receptor activityGreg N Brooke, Sue M Powell, Derek N Lavery, et al.
Breast Cancer Research : BCR|November 17, 2020
Activating transcription factor-2 (ATF2) is a key determinant of resistance to endocrine treatment in an in vitro model of breast cancerAthina Giannoudis, Mohammed Imad Malki, Bharath Rudraraju, et al.
The EMBO Journal|September 8, 2025
Resistance to CDK7 inhibitors directed by acquired mutation of a conserved residue in cancer cellsChun-Fui Lai, Victoria I Cushing, Ellen Olden, et al.
Cancers|May 16, 2023
The CDK4/6 Inhibitor Palbociclib Inhibits Estrogen-Positive and Triple Negative Breast Cancer Bone Metastasis In VivoLubaid Saleh, Penelope D Ottewell, Janet E Brown, et al.
Biochemical Pharmacology|July 23, 2021
MicroRNA-495/TGF-β/FOXC1 axis regulates multidrug resistance in metaplastic breast cancer cellsUttom Kumar, Yunhui Hu, Nahal Masrour, et al.
Pageof 12

Showing results (21-30 of 111) with videos related to

Sort By:
Pageof 12
The Journal of Steroid Biochemistry and Molecular Biology|October 4, 2002
Molecular changes associated with the acquisition of oestrogen hypersensitivity in MCF-7 breast cancer cells on long-term oestrogen deprivationChristina M W Chan, Lesley-Ann Martin, Stephen R D Johnston, et al.
Endocrinology|May 8, 2024
Interrogating Estrogen Signaling Pathways in Human ER-Positive Breast Cancer Cells Forming Bone Metastases in MiceJulia N Cheng, Jennifer B Frye, Susan A Whitman, et al.
Bioorganic & Medicinal Chemistry Letters|August 3, 2020
The transcriptional repressor REV-ERB as a novel target for diseaseAmaia Uriz-Huarte, Amrita Date, Heather Ang, et al.
The Journal of Organic Chemistry|June 8, 2011
Conversion of α-amino acids into bioactive o-aminoalkyl resorcylates and related dihydroxyisoindolinonesBhavesh H Patel, Andrew M Mason, Hetal Patel, et al.
Nature Communications|March 17, 2018
Light-triggered enzymatic reactions in nested vesicle reactorsJames W Hindley, Yuval Elani, Catriona M McGilvery, et al.
Oncotarget|March 25, 2014
Engineered repressors are potent inhibitors of androgen receptor activityGreg N Brooke, Sue M Powell, Derek N Lavery, et al.
Breast Cancer Research : BCR|November 17, 2020
Activating transcription factor-2 (ATF2) is a key determinant of resistance to endocrine treatment in an in vitro model of breast cancerAthina Giannoudis, Mohammed Imad Malki, Bharath Rudraraju, et al.
The EMBO Journal|September 8, 2025
Resistance to CDK7 inhibitors directed by acquired mutation of a conserved residue in cancer cellsChun-Fui Lai, Victoria I Cushing, Ellen Olden, et al.
Cancers|May 16, 2023
The CDK4/6 Inhibitor Palbociclib Inhibits Estrogen-Positive and Triple Negative Breast Cancer Bone Metastasis In VivoLubaid Saleh, Penelope D Ottewell, Janet E Brown, et al.
Biochemical Pharmacology|July 23, 2021
MicroRNA-495/TGF-β/FOXC1 axis regulates multidrug resistance in metaplastic breast cancer cellsUttom Kumar, Yunhui Hu, Nahal Masrour, et al.
Pageof 12